Ocular Therapeutix's top three insider shareholders as of May 30, 2026 are Road Llc Summer (TenPercentOwner, 8.59Mn shares), Pravin Dugel (Executive Chairman, 2.62Mn shares), Antony C. Mattessich (President And Ceo, 588.70K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Richard L Md Lindstrom | - | 246,933 | 0 | 24 Feb, 2026 |
| Adrienne L Graves | - | 50,000 | 0 | 13 Jun, 2025 |
| Charles M Warden | - | 86,464 | 0 | 13 Jun, 2025 |
| Christopher G White | Chief Business Officer | 123,689 | 0 | 06 Feb, 2024 |
| Road Llc Summer | - | 0 | 8,591,401 | 27 Feb, 2024 |
| Jeffrey S. Heier | Chief Scientific Officer | 323,368 | 0 | 25 Feb, 2026 |
| Michael H. Goldstein | President, Ophthalmology Cmo | 313,335 | 0 | 07 Feb, 2022 |
| Pravin Dugel | Executive Chairman | 2,618,326 | 0 | 13 Apr, 2026 |
| Antony C. Mattessich | President And Ceo | 588,701 | 0 | 06 Feb, 2024 |
| Donald Notman | Chief Operating Officer | 366,356 | 0 | 17 Feb, 2026 |
| Leslie J. Williams | - | 51,433 | 0 | 13 Jun, 2025 |
| Seung Suh Hong | - | 46,933 | 0 | 13 Jun, 2025 |
| Rabia Gurses Ozden | Chief Medical Officer | 153,054 | 0 | 06 Feb, 2024 |
| Philip C. Strassburger | General Counsel | 161,493 | 0 | 06 Feb, 2024 |
| Peter Kaiser | Chief Development Officer | 269,108 | 0 | 25 Feb, 2026 |
| Sanjay Nayak | Chief Strategy Officer | 330,653 | 0 | 25 Feb, 2026 |
| Nadia Waheed | Chief Medical Officer | 314,907 | 0 | 24 Feb, 2026 |
| Todd Anderman | Chief Legal Officer | 152,468 | 0 | 06 Jan, 2026 |
| Namrata Saroj | Chief Business Officer | 254,620 | 0 | 06 Jan, 2026 |
| Steve Lawrence Meyers | Chief Commercial Officer | 217,628 | 0 | 06 Jan, 2026 |
| David Wayne Robinson | Global Cco | 136,000 | 0 | 26 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Pravin Dugel | Common Stock | D | 394,696 | $0.00 | 2,618,326 | D | G |
| 09 Apr, 2026 | Pravin Dugel | Common Stock | A | 394,696 | $0.00 | 394,696 | I | G |
| 23 Feb, 2026 | Sanjay Nayak | Common Stock | D | 1,759 | $8.28 | 330,653 | D | S |
| 23 Feb, 2026 | Jeffrey S. Heier | Common Stock | D | 3,057 | $8.28 | 323,368 | D | S |
| 23 Feb, 2026 | Pravin Dugel | Common Stock | D | 20,056 | $8.28 | 3,013,022 | D | S |
| 23 Feb, 2026 | Peter Kaiser | Common Stock | D | 2,810 | $8.28 | 269,108 | D | S |
| 20 Feb, 2026 | Nadia Waheed | Common Stock | D | 3,510 | $7.74 | 314,907 | D | S |
| 20 Feb, 2026 | Nadia Waheed | Common Stock | D | 3,510 | $7.74 | 314,907 | D | S |
| 20 Feb, 2026 | Richard L Md Lindstrom | Common Stock | A | 60,229 | $7.66 | 246,933 | D | P |
| 20 Feb, 2026 | Nadia Waheed | Common Stock | D | 3,510 | $7.74 | 314,907 | D | S |
| 12 Feb, 2026 | Pravin Dugel | Common Stock | D | 124,882 | $9.04 | 3,033,078 | D | S |
| 12 Feb, 2026 | Nadia Waheed | Common Stock | D | 7,863 | $9.04 | 318,417 | D | S |
| 12 Feb, 2026 | Nadia Waheed | Common Stock | D | 7,863 | $9.04 | 318,417 | D | S |
| 12 Feb, 2026 | Nadia Waheed | Common Stock | D | 7,863 | $9.04 | 318,417 | D | S |
| 12 Feb, 2026 | Sanjay Nayak | Common Stock | D | 10,348 | $9.04 | 332,412 | D | S |
| 12 Feb, 2026 | Donald Notman | Common Stock | D | 11,446 | $9.04 | 366,356 | D | S |
| 02 Feb, 2026 | Donald Notman | Common Stock | D | 5,455 | $9.14 | 383,837 | D | S |
| 04 Feb, 2026 | Donald Notman | Common Stock | D | 6,035 | $8.54 | 377,802 | D | S |
| 21 Jan, 2026 | David Wayne Robinson | Common Stock | A | 136,000 | $0.00 | 136,000 | D | A |
| 21 Jan, 2026 | David Wayne Robinson | Common Stock | A | 136,000 | $0.00 | 136,000 | D | A |